CGS-CIMB analyst William Tng has maintained his “buy” call on Grand Venture Technology after the release of its 1QFY2022 ended March business update on May 6, but has cut the target price from $1.60 to $1.29Grand Venture’s 1QFY2022 posted a net profit after tax (npat) of $3.6 million, 8.9% hig...

The company’s life sciences segment will also benefit from growing mass spectrometer demand, and advancements in medical technologies will be advantageous to GVT’s electronics and medical segment.As such, she expects margins to improve after 1QFY2022, adding that “the overall macroeconomic env...

DBS on Monday (May 9) lowered Grand Venture Technology’s target price to S$1.40 from S$1.50 while maintaining a “buy” rating. This comes as the research team anticipates near-term margin compression.

Grand Venture Technology has posted net profit after tax (npat) of $3.6 million for the 1QFY2022 ended March, 8.9% higher than npat of $3.3 million in the corresponding quarter the year before.Revenue for the quarter surged by 41.0% y-o-y to $32.5 million.Gross profit and ebitda increased by a respe...

CATALIST-LISTED manufacturing-service provider Grand Venture Technology on Friday (May 6) posted a first-quarter net profit after tax of S$3.6 million, up 8.9 per cent from S$3.3 million a year ago.

GRAND Venture Technology (GVT) is likely "well-poised" to gain from the positive industry outlook on all 3 of its segments, which includes the semiconductor, life sciences, and electronics and medical segments, said DBS Group Research.

The DBS team thinks Grand Venture Tech is well poised to take advantage of these industry trends, saying that the company is in expansion mode�in the last two years. GVT�capex spending, acquisition of new facilities and new capabilities will allow GVT to ramp up production, increase wallet share, an...

GRAND Venture Technology (GVT) is likely "well-poised" to gain from the positive industry outlook on all 3 of its segments, which includes the semiconductor, life sciences, and electronics and medical segments, said DBS Group Research.

SAC Capital analyst Lim Shu Rong has upgraded her recommendation on Grand Venture Technology to “buy” from “hold” previously. Lim’s upgrade on March 18 comes as the precision manufacturing firm’s results for the FY2021 ended December stood above expectations. During the year, Grand Ven...

EXPECTATIONS of higher cost of debt and market risks have prompted SAC Capital to lower its target price for Grand Venture Technology to S$1.195 from S$1.30.